Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.68 |
| ▸ | CA1 | P00915 | 11/20 | 0.68 |
| ▸ | CA9 | Q16790 | 10/20 | 0.68 |
| ▸ | CA12 | O43570 | 10/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | CA7 | P43166 | 6/20 | 0.58 |
| ▸ | CA5A | P35218 | 5/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.58 |
| ▸ | CA6 | P23280 | 3/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.58 |
| ▸ | CA4 | P22748 | 2/20 | 0.58 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.58 |
| ▸ | CA3 | P07451 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9423733 | 0.98 | CA2 (0.66) | CA2CA1CA9CA12ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3532247 | 0.98 | CA2 (0.66) | CA2CA1CA9CA12ALDH1A1 | |
| Fluoride SCHEMBL28353367 | 0.98 | CA2 (0.66) | CA2CA1CA9CA12ALDH1A1 | |
| Benzenesulfonamide SCHEMBL9819524 | 0.85 | CA2 (0.67) | CA2CA1CA9CA12ALDH1A1 | |
| Sulfanilamide SCHEMBL27568655 | 0.84 | CA2 (0.63) | CA2CA1CA9CA12ALDH1A1 | |
| SCHEMBL8248221 | 0.84 | ALDH1A1 (0.62) | CA2CA1CA9CA12ALDH1A1 | |
| SCHEMBL1186051 | 0.84 | ALDH1A1 (0.62) | CA2CA1CA9CA12ALDH1A1 | |
| SCHEMBL1790668 | 0.84 | ALDH1A1 (0.62) | CA2CA1CA9CA12ALDH1A1 | |
| SCHEMBL672750 | 0.82 | CA2 (1.00) | CA2CA1CA9CA12CA7 | |
| SCHEMBL12112205 | 0.82 | ALDH1A1 (0.60) | CA2CA1CA9CA12ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119233829-A | Pharmaceutical composition for preventing, inhibiting or treating symptoms associated with pseudoallergy | 学校法人高崎健康福祉大学 | 2024-12-31 | — | — | CN | claimed |
| CN-118176003-A | Medicaments comprising P2X4 receptor antagonists for the prevention or treatment of nociceptive pain and/or visceral pain | 日本化学药品株式会社 | 2024-06-11 | — | — | CN | claimed |
| CN-118019551-A | Preventive or therapeutic agent for respiratory diseases | 日本化学药品株式会社 | 2024-05-10 | — | — | CN | claimed |
| CN-115942938-A | Medicine for preventing or treating irritable bowel syndrome or inflammatory bowel disease | 比萨大学 | 2023-04-07 | — | — | CN | claimed |
| CN-108928879-B | Electroplating sewage treatment agent and preparation method thereof | 江苏艾特克环境工程有限公司 | 2021-04-13 | — | — | CN | claimed |
| US-10201957-B2 | Dye receiving layer composition, dye receiving substrate and method of fabricating the same | CHIEN HWA COATING TECHNOLOGY , INC. (TW) | 2019-02-12 | — | — | US | claimed |
| CN-108440856-A | Dye-colored body and method for producing same | 谦华科技股份有限公司 | 2018-08-24 | — | — | CN | claimed |
| EP-3363650-A1 | DYE RECEIVING LAYER COMPOSITION, DYE RECEIVING SUBSTRATE AND METHOD OF FABRICATING THE SAME | Chien Hwa Coating Technology, Inc. (TW) | 2018-08-22 | — | — | EP | claimed |
| CN-101709045-B | Preparation method of thiophenol | UNIV ZHEJIANG | 2013-02-27 | — | — | CN | claimed |
| WO-2011021216-A2 | IMPROVED PROCESS FOR THE PREPARATION OF 4-(1,1-DIMETHYLETHYL)-N-[6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)[2,2'-BIPYRIMIDIN]-4-YL]BENZENESULFONAMIDE | MSN LABORATORIES LIMITED (IN) | 2011-02-24 | — | — | WO | claimed |
| CN-101709045-A | Preparation method of thiophenol | UNIV ZHEJIANG | 2010-05-19 | — | — | CN | claimed |
| EP-2097414-A1 | PYRROLO [2, 3-B]PYRIDINE DERIVATIVES AS KINASE MODULATORS | PLEXXIKON, INC. (US) | 2009-09-09 | — | — | EP | claimed |
| WO-2008079906-A1 | PYRROLO [2, 3-B] PYRIDINE DERIVATIVES AS KINASE MODULATORS | PLEXXIKON, INC. (US) | 2008-07-03 | — | — | WO | claimed |
| US-12458624-B2 | Deuterium-enriched substituted phenoxyphenyl acetic acids and acylsulfonamides | DHANOA DALJIT SINGH (US) | 2025-11-04 | — | — | US | disclosed |
| CN-119954725-A | TEAD inhibitors and uses thereof | 医肯纳肿瘤学公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119306668-A | Benzimidazole compound, and preparation method and application thereof | 中国医学科学院药物研究所 | 2025-01-14 | — | — | CN | disclosed |
| US-5270313-A | Treatment of circulatory disorders | HOFFMANN-LA ROCHE INC. (US) | 1993-12-14 | — | — | US | disclosed |
| EP-0526708-A1 | Sulfonamide, preparation and use thereof as medicine and intermediate | F. HOFFMANN-LA ROCHE AG (CH) | 1993-02-10 | — | — | EP | disclosed |
| EP-0510526-A1 | Use of sulfonamides as drug and new sulfonamides | F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) | 1992-10-28 | — | — | EP | disclosed |
| US-4168375-A | Process for the recovery of cephalosporin C and derivatives thereof | ALFA FARMACEUTICI, S.P.A. (IT) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458624-B2 | Deuterium-enriched substituted phenoxyphenyl acetic acids and acylsulfonamides | AGTR2, AGTR1, EDNRA | CA2 574/4885CA1 2870/4885CA9 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.